Guidelines
HAP/VAP with Risk Factors

HAP/VAP with Risk Factors

Duration

3 days of therapy can be considered for questionable pneumonia and patient improves

7 days of therapy for confirmed pneumonia/good clinical response

10-14 days if poor clinical response/severe immunocompromised